These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24847054)

  • 1. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.
    Xie R; Xu J; Wen G; Jin H; Liu X; Yang Y; Ji B; Jiang Y; Song P; Dong H; Tuo B
    J Biol Chem; 2014 Jul; 289(27):19137-49. PubMed ID: 24847054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ATP and Purinergic P2Y
    Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
    Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells.
    Tak E; Jun DY; Kim SH; Park GC; Lee J; Hwang S; Song GW; Lee SG
    J Int Med Res; 2016 Dec; 44(6):1234-1247. PubMed ID: 27807254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.
    Khalid M; Brisson L; Tariq M; Hao Y; Guibon R; Fromont G; Mortadza SAS; Mousawi F; Manzoor S; Roger S; Jiang LH
    Oncotarget; 2017 Jun; 8(23):37278-37290. PubMed ID: 28418839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y
    Zaparte A; Cappellari AR; Brandão CA; de Souza JB; Borges TJ; Kist LW; Bogo MR; Zerbini LF; Ribeiro Pinto LF; Glaser T; Gonçalves MCB; Naaldijk Y; Ulrich H; Morrone FB
    Eur J Pharmacol; 2021 Jan; 891():173687. PubMed ID: 33130276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y
    Khalafalla FG; Greene S; Khan H; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Nguyen J; Norman B; Dembitsky WP; Sussman MA
    Circ Res; 2017 Nov; 121(11):1224-1236. PubMed ID: 28923792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
    Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
    Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca(2+) spiking activity caused by the activation of store-operated Ca(2+) channels mediates TNF-α release from microglial cells under chronic purinergic stimulation.
    Ikeda M; Tsuno S; Sugiyama T; Hashimoto A; Yamoto K; Takeuchi K; Kishi H; Mizuguchi H; Kohsaka SI; Yoshioka T
    Biochim Biophys Acta; 2013 Dec; 1833(12):2573-2585. PubMed ID: 23830920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP promotes resident CD34
    Ma Y; Han C; Xie C; Dang Q; Yang L; Li Y; Zhang M; Cheng J; Yang Y; Xu Q; Li P
    Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1228-C1243. PubMed ID: 37721000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal exocytosis of ATP is coupled to P2Y
    Liu B; Cao W; Li J; Liu J
    Cell Calcium; 2018 Dec; 76():62-71. PubMed ID: 30273839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.
    Maynard JP; Lee JS; Sohn BH; Yu X; Lopez-Terrada D; Finegold MJ; Goss JA; Thevananther S
    Oncotarget; 2015 Dec; 6(38):41162-79. PubMed ID: 26517690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.
    Martinez NA; Ayala AM; Martinez M; Martinez-Rivera FJ; Miranda JD; Silva WI
    J Biol Chem; 2016 Jun; 291(23):12208-22. PubMed ID: 27129210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activation.
    Byun YS; Yoo YS; Kwon JY; Joo JS; Lim SA; Whang WJ; Mok JW; Choi JS; Joo CK
    Exp Eye Res; 2016 Feb; 143():89-97. PubMed ID: 26505315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover.
    Yang N; Tang Y; Wang F; Zhang H; Xu D; Shen Y; Sun S; Yang G
    Cancer Lett; 2013 Apr; 330(2):163-9. PubMed ID: 23211538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
    Jin H; Ko YS; Kim HJ
    Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y
    Sophocleous RA; Miles NA; Ooi L; Sluyter R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.